CIK 0000014272 · Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 220790350
- Phone
- 6092524621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-31 | Bhatt Deepak Director | Grant or award · Deferred Share Units | +164.44 | $51.31 | $8K | 5,506.37 |
| 2023-12-31 | Arduini Peter J Director | Grant or award · Deferred Share Units | +657.77 | $51.31 | $34K | 47,167 |
| 2023-12-05 | BOERNER CHRISTOPHER S. Chief Executive Officer | Purchase | +2,000 | $49.78 | $100K | 82,672 |
| 2023-12-02 | Plenge Robert M EVP, Chief Research Officer | Option exercise | +616 | 7,200 | ||
| 2023-12-02 | Plenge Robert M EVP, Chief Research Officer | Shares withheld for taxes | −274 | $50.10 | $14K | 6,926 |
| 2023-12-02 | Plenge Robert M EVP, Chief Research Officer | Option exercise · Restricted Stock Units | −616 | 0 | ||
| 2023-12-02 | Elkins David V EVP, Chief Financial Officer | Option exercise | +8,792 | 172,342 | ||
| 2023-12-02 | Elkins David V EVP, Chief Financial Officer | Shares withheld for taxes | −3,730 | $50.10 | $187K | 168,612 |
| 2023-12-02 | Elkins David V EVP, Chief Financial Officer | Option exercise · Restricted Stock Units | −8,792 | 0 | ||
| 2023-12-02 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise | +2,638 | 82,022 | ||
| 2023-12-02 | BOERNER CHRISTOPHER S. Chief Executive Officer | Shares withheld for taxes | −1,350 | $50.10 | $68K | 80,672 |
| 2023-12-02 | BOERNER CHRISTOPHER S. Chief Executive Officer | Option exercise · Restricted Stock Units | −2,638 | 0 | ||
| 2023-11-28 | BOERNER CHRISTOPHER S. Chief Executive Officer | Purchase | +3,071 | $48.86 | $150K | 79,384 |
| 2023-11-21 | LEUNG SANDRA EVP, General Counsel | Other disposition | −9,830 | $48.75 | $479K | 331,414.33 |
| 2023-11-21 | LEUNG SANDRA EVP, General Counsel | Other acquisition | +9,830 | $48.75 | $479K | 93,436 |
| 2023-11-20 | Samuels Theodore R. II Director | Purchase | +8,500 | $49.81 | $423K | 35,500 |
| 2023-11-01 | BOERNER CHRISTOPHER S. Chief Executive Officer | Grant or award · Market Share Units | +11,858 | 11,858 | ||
| 2023-11-01 | BOERNER CHRISTOPHER S. Chief Executive Officer | Grant or award · Performance Shares | +17,788 | 17,788 | ||
| 2023-10-10 | Caforio Giovanni Board Chair and CEO | Gift | −440 | 367,495.33 |
Page 40 of 40 · 799 trades